Position in OGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,570
-$4,640 QoQ
Shares Held
3,768
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,570 | 3,768 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,210 | 3,795 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,258 | 1,616 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,836 | 1,636 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $351,940 | 23,636 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $352,634 | 23,635 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $260,837 | 13,635 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $282,223 | 13,634 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $256,319 | 13,634 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $197,539 | 13,699 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,596,500 | 149,568 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,886,391 | 186,756 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,601,005 | 195,621 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $8,551,299 | 306,169 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,202,732 | 222,339 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,872,144 | 292,508 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,445,257 | 299,034 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,934,881 | 293,428 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,931,799 | 272,394 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $132,508 | 4,379 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||